Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.

MLA

Chen, Xiang-Fan, et al. “Arctigenin Inhibits the Progression of Colorectal Cancer through Epithelial-Mesenchymal Transition via PI3K/Akt/MTOR Signaling Pathway.” PloS One, vol. 19, no. 9, Sept. 2024, p. e0308947. EBSCOhost, https://doi.org/10.1371/journal.pone.0308947.

APA

Chen, X.-F., Liu, P.-G., Sheng, N., Li, X.-S., Hu, R.-K., Zhu, L.-X., & Feng, P. (2024). Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway. PloS One, 19(9), e0308947. https://doi.org/10.1371/journal.pone.0308947

Chicago

Chen, Xiang-Fan, Pei-Gen Liu, Nan Sheng, Xin-Shuai Li, Rui-Kun Hu, Long-Xun Zhu, and Panfeng Feng. 2024. “Arctigenin Inhibits the Progression of Colorectal Cancer through Epithelial-Mesenchymal Transition via PI3K/Akt/MTOR Signaling Pathway.” PloS One 19 (9): e0308947. doi:10.1371/journal.pone.0308947.